GENE

Genetic Technologies (GENE)

Genetic Technologies Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GENE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/05	21 : 00	GlobeNewswire Inc.	GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test	NASDAQ:GENE	Genetic Technologies Ltd
2024/06/05	19 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/05/29	21 : 00	GlobeNewswire Inc.	GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer	NASDAQ:GENE	Genetic Technologies Ltd
2024/05/29	19 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/05/28	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GENE	Genetic Technologies Ltd
2024/05/23	21 : 00	GlobeNewswire Inc.	GeneType and Humanise Health host “Know Your Risk” Event	NASDAQ:GENE	Genetic Technologies Ltd
2024/05/06	21 : 00	GlobeNewswire Inc.	GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/23	04 : 00	GlobeNewswire Inc.	Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/19	01 : 17	GlobeNewswire Inc.	Genetic Technologies Announces $2 Million Registered Direct Offering	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/17	21 : 00	GlobeNewswire Inc.	New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/16	21 : 00	GlobeNewswire Inc.	GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/11	21 : 00	GlobeNewswire Inc.	GTG to pilot GeneType in Breast Screen centers across the U.S.	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/08	21 : 00	GlobeNewswire Inc.	EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”	NASDAQ:GENE	Genetic Technologies Ltd
2024/04/02	21 : 05	GlobeNewswire Inc.	Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market	NASDAQ:GENE	Genetic Technologies Ltd
2024/03/26	21 : 00	GlobeNewswire Inc.	GTG Global Collaborations and Innovation Update	NASDAQ:GENE	Genetic Technologies Ltd
2024/03/25	21 : 00	GlobeNewswire Inc.	GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare	NASDAQ:GENE	Genetic Technologies Ltd
2024/02/26	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/02/15	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/02/15	04 : 14	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/31	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/31	22 : 00	GlobeNewswire Inc.	Launching our most comprehensive test and expanding into new global markets	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/09	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/05	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/05	22 : 00	GlobeNewswire Inc.	Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:GENE	Genetic Technologies Ltd
2024/01/05	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GENE	Genetic Technologies Ltd
2023/12/28	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2023/12/27	22 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GENE	Genetic Technologies Ltd
2023/12/21	07 : 00	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:GENE	Genetic Technologies Ltd
2023/12/14	22 : 00	GlobeNewswire Inc.	GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness	NASDAQ:GENE	Genetic Technologies Ltd
2023/12/12	22 : 00	GlobeNewswire Inc.	Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change	NASDAQ:GENE	Genetic Technologies Ltd